Alexion Pharmaceuticals, Inc. ALXN
182.50 +182.50
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2020 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 | FY 2016 Dec 31, 2016 |
|---|---|---|---|---|---|
| 6.07B | 4.99B | 4.13B | 3.55B | 3.08B | |
| 6.07B | 4.99B | 4.13B | 3.55B | 3.08B | |
| 553.50M | 394.50M | 374.30M | 454.20M | 258.30M | |
| 5.52B | 4.60B | 3.76B | 3.10B | 2.83B | |
| 4.84B | 2.46B | 3.37B | 2.43B | 2.12B | |
| 1.00B | 886.00M | 730.40M | 878.40M | 757.20M | |
| 1.40B | 1.26B | 1.11B | 1.09B | 953.00M | |
| 678.70M | 2.13B | 386.10M | 668.40M | 703.10M | |
| 104.70M | 77.80M | 98.20M | 98.40M | 96.90M | |
| -34.40M | -225.50M | 164.60M | 104.50M | 176.80M | |
| 603.40M | 2.40B | 77.60M | 443.30M | 399.40M | |
| 603.40M | 2.40B | 77.60M | 443.30M | 399.40M | |
| 603.40M | 2.40B | 77.60M | 443.30M | 399.40M | |
| 603.40M | 2.40B | 77.60M | 443.30M | 399.40M | |
| 2.74 | 10.77 | 0.35 | 1.98 | 1.78 | |
| 2.74 | 10.77 | 0.35 | 1.98 | 1.78 | |
| 2.72 | 10.70 | 0.35 | 1.97 | 1.76 | |
| 673.70M | 2.26B | 340.40M | 646.20M | 673.10M | |
| 673.70M | 2.26B | 340.40M | 646.20M | 673.10M | |
| 220.10M | 223.20M | 222.70M | 223.90M | 224.30M | |
| 222.00M | 224.80M | 224.50M | 225.40M | 226.30M |